Ozone Body Protection Cream
NDC Package 82779-002-02
Package Information
Ozone Body Protection Cream is a . Marketed by Humanrace, this product is identified by NDC 82779-002 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82779 - Humanrace
- 82779-002 - Ozone Body Protection Cream
- 82779-002-02 - 1 BOTTLE, PUMP in 1 CARTON / 148 mL in 1 BOTTLE, PUMP
- 82779-002 - Ozone Body Protection Cream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82779-002-02 identifies a specific commercial package of 1 bottle, pump in 1 carton / 148 ml in 1 bottle, pump of Ozone Body Protection Cream, labeled by Humanrace. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Humanrace on June 10, 2022. The current certification is valid through August 18, 2023.
How is this Humanrace product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82779000202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.